The impact of azole antifungal drugs on imatinib metabolism in human liver microsomes

References

• Barratt DT, Cox HK, Menelaou A, et al. (2016). CYP2C8 genotype significantly alters imatinib metabolism in chronic myeloid leukaemia patients. Clin Pharmacokinet 56:1–9.
   Web of Science ®Google Scholar
• Dutreix C, Peng B, Mehring G, et al. (2004). Pharmacokinetic interaction between ketoconazole and imatinib mesylate (Glivec) in healthy subjects. Cancer Chemother Pharmacol 54:290.
   PubMed Web of Science ®Google Scholar
• Eechoute K, Sparreboom A, Burger H, et al. (2011). Drug transporters and imatinib treatment: implications for clinical practice. Clin Cancer Res 17:406–15.
   PubMed Web of Science ®Google Scholar
• Filppula AM, Neuvonen M, Laitila J, et al. (2013a). Autoinhibition of CYP3A4 leads to important role of CYP2C8 in imatinib metabolism: variability in CYP2C8 activity may alter plasma concentrations and response. Drug Metab Dispos 41:50–9.
   PubMed Web of Science ®Google Scholar
• Filppula AM, Tornio A, Niemi M, et al. (2013b). Gemfibrozil impairs imatinib absorption and inhibits the CYP2C8-mediated formation of its main metabolite. Clin Pharmacol Ther 35:383–93.
   Web of Science ®Google Scholar
• Francis J, Dubashi B, Sundaram R, et al. (2015). A study to explore the correlation of ABCB1, ABCG2, OCT1 genetic polymorphisms and trough level concentration with imatinib mesylate-induced thrombocytopenia in chronic myeloid leukemia patients. Cancer Chemother Pharmacol 76:1185–9.
   PubMed Web of Science ®Google Scholar
• Gambillara E, Laffitte E, Widmer N, et al. (2005). Severe pustular eruption associated with imatinib and voriconazole in a patient with chronic myeloid leukemia. Dermatology 211:363–5.
   PubMed Web of Science ®Google Scholar
• Gibbs MA, Thummel KE, Shen DD, Kunze KL. (1999). Inhibition of cytochrome P-450 3A (CYP3A) in human intestinal and liver microsomes: comparison of Ki values and impact of CYP3A5 expression. Drug Metab Dispos 27:180–7.
   PubMed Web of Science ®Google Scholar
• Groll AH, Castagnola E, Cesaro S, et al. (2014). Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation. Lancet Oncol 15:e327–40.
   PubMed Web of Science ®Google Scholar
• Groll AH, Townsend R, Desai A, et al. (2017). Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4. Transpl Infect Dis 19:e12751.
   PubMed Web of Science ®Google Scholar
• Guengerich FP. (2008). Cytochrome p450 and chemical toxicology. Chem Res Toxicol 21:70–83.
   PubMed Web of Science ®Google Scholar
• Hamadeh IS, Klinker KP, Borgert SJ, et al. (2017). Impact of the CYP2C19 genotype on voriconazole exposure in adults with invasive fungal infections. Pharmacogenet Genomics 27:190.
   PubMed Web of Science ®Google Scholar
• Isoherranen N, Kunze KL, Allen KE, et al. (2004). Role of itraconazole metabolites in CYP3A4 inhibition. Drug Metab Dispos 32:1121–31.
   PubMed Web of Science ®Google Scholar
• Jeong S, Nguyen PD, Desta Z. (2009a). Comprehensive in vitro analysis of voriconazole inhibition of eight cytochrome P450 (CYP) enzymes: major effect on CYPs 2B6, 2C9, 2C19, and 3A. Antimicrob Agents Chemother 53:541–51.
   PubMed Web of Science ®Google Scholar
• Jeong S, Nguyen PD, Desta Z. (2009b). Comprehensive in vitro analysis of voriconazole inhibition of eight cytochrome P450 (CYP) enzymes: major effect on CYPs 2B6, 2C9, 2C19, and 3A. Antimicrob Agents Chemother 53:541–51.
   PubMed Web of Science ®Google Scholar
• Jiang W, Wang X, Xu X, Kong L. (2010). Effect of Schisandra sphenanthera extract on the concentration of tacrolimus in the blood of liver transplant patients. Int J Clin Pharmacol Ther 48:224–9.
   PubMed Web of Science ®Google Scholar
• Kaartama R, Jarho P, Savolainen J, et al. (2011). Determination of midazolam and 1-hydroxymidazolam from plasma by gas chromatography coupled to methane negative chemical ionization mass spectrometry after sublingual administration of midazolam. J Chromatogr B 879:1668–76.
   PubMed Web of Science ®Google Scholar
• Kc VDE, Pereboom M, Er VDH, et al. (2014). Insufficient fluconazole exposure in pediatric cancer patients and the need for therapeutic drug monitoring in critically ill children. Clin Infect Dis 59:1527–33.
   PubMed Web of Science ®Google Scholar
• Khan MS, Barratt DT, Somogyi AA. (2015). Impact of CYP2C8*3 polymorphism on in vitro metabolism of imatinib to N-desmethyl imatinib. Xenobiotica 46:278–87.
   PubMed Web of Science ®Google Scholar
• Kim H, Shin D, Kang HJ, et al. (2015). Successful empirical antifungal therapy of intravenous itraconazole with pharmacokinetic evidence in pediatric cancer patients undergoing hematopoietic stem cell transplantation. Clin Drug Investig 35:437–46.
   PubMed Web of Science ®Google Scholar
• Kozakai K, Yamada Y, Oshikata M, et al. (2014). Cocktail-substrate approach-based high-throughput assay for evaluation of direct and time-dependent inhibition of multiple cytochrome P450 isoforms. Drug Metab Pharmacok 29:198–207.
   PubMed Web of Science ®Google Scholar
• Lazar JD, Wilner KD. (1990). Drug interactions with fluconazole. Rev Infect Dis 12:S327–S33.
   PubMedGoogle Scholar
• Lin G, Wang C, Qiu X, et al. (2014). Differential effects of ketoconazole, itraconazole and voriconazole on the pharmacokinetics of imatinib and its main metabolite GCP74588 in rat. Drug Dev Ind Pharm 40:1616–22.
   PubMed Web of Science ®Google Scholar
• Moody DE, Liu F, Fang WB. (2015). Azole antifungal inhibition of buprenorphine, methadone and oxycodone in vitro metabolism. J Anal Toxicol 39:374–86.
   PubMed Web of Science ®Google Scholar
• Nebot N, Crettol S, D'Esposito F, et al. (2010). Participation of CYP2C8 and CYP3A4 in the N-demethylation of imatinib in human hepatic microsomes. Br J Pharmacol 161:1059.
   PubMed Web of Science ®Google Scholar
• Niwa T, Shiraga T, Takagi A. (2005). Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes. Biol Pharm Bull 28:1805–8.
   PubMed Web of Science ®Google Scholar
• O'Brien SG, Meinhardt P, Bond E, et al. (2003). Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome p450 3A4 substrate, in patients with chronic myeloid leukaemia. Br J Cancer 89:1855–9.
   PubMed Web of Science ®Google Scholar
• Peng B, Lloyd P, Schran H. (2005). Clinical pharmacokinetics of imatinib. Clin Pharmacokinet 44:879–94.
   PubMed Web of Science ®Google Scholar
• Peterlin P, Chauvin C, Le SG, et al. (2018). Fungal prophylaxis with a gastro-resistant posaconazole tablet for patients with hematological malignancies: final result of the POSANANTES study. Antimicrob Agents Chemother AAC 62:01746-17.
   PubMed Web of Science ®Google Scholar
• Solano C, Slavin M, Shaul AJ, et al. (2017). Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplant. Mycoses 60:79–88.
   PubMed Web of Science ®Google Scholar
• VAN Erp NP, Gelderblom H, Karlsson MO, et al. (2007). Influence of CYP3A4 inhibition on the steady-state pharmacokinetics of imatinib. Clinic Cancer Res 13:7394–400.
   PubMed Web of Science ®Google Scholar
• VON Moltke LL, Greenblatt DJ, Schmider J, et al. (1996). Midazolam hydroxylation by human liver microsomes in vitro: inhibition by fluoxetine, norfluoxetine, and by azole antifungal agents. J Clin Pharmacol 36:783–91.
   PubMed Web of Science ®Google Scholar
• Wexler D, Courtney R, Richards W, et al. (2004). Effect of posaconazole on cytochrome P450 enzymes: a randomized, open-label, two-way crossover study. Eur J Pharm Sci 21:645–53.
   PubMed Web of Science ®Google Scholar
• Xin HW, Li Q, Wu XC, et al. (2011). Effects of Schisandra sphenanthera extract on the blood concentration of tacrolimus in renal transplant recipients. Eur J Clin Pharmacol 67:1309–11.
   PubMed Web of Science ®Google Scholar
• Zhang S, Pillai VC, Mada SR, et al. (2012). Effect of voriconazole and other azole antifungal agents on CYP3A activity and metabolism of tacrolimus in human liver microsomes. Xenobiotica 42:409–16.
   PubMed Web of Science ®Google Scholar
• Zhong JS, Meng FY, Xu D, et al. (2012). Correlation between imatinib trough concentration and efficacy in chinese chronic myelocytic leukemia patients. Acta Haematologica 127:221–7.
   PubMed Web of Science ®Google Scholar